The growing numbers of infants born to women with opioid use disorder (OUD) and
experiencing neonatal abstinence syndrome (NAS), and the increasing costs of their care, 1 …

Background Few coordinated treatment programs address the needs of infants and families
struggling with the effects of substance use. In 2003 a large Southeastern regional hospital …

The opioid abuse problem in the United States has grown into an epidemic, with an
estimated 2.5 million Americans currently dependent on heroin or prescription pain …

Neonatal abstinence syndrome (NAS) is a variable, complex, and incompletely understood
spectrum of neonatal neurobehavioral dysregulation associated with prenatal drug …

OBJECTIVES: Neonatal abstinence syndrome (NAS) after an infant's in-utero exposure to
opioids has increased dramatically in incidence. No treatment standards exist, leading to …

There has been increasing emphasis on the importance of the development of self-
regulatory capacities of the individual as the cornerstone of development. The caregivers' …

Abstract Objectives To improve Neonatal Abstinence Syndrome (NAS) inpatient outcomes
through a comprehensive quality improvement (QI) program. Design Inclusion criteria were …

Background and Purpose Opioid use disorder is an ever-expanding health epidemic
affecting populations across the lifespan. Infants diagnosed with neonatal abstinence …

BACKGROUND: At our institution, the treatment of infants with neonatal abstinence
syndrome (NAS) is guided by a function-based assessment called the Eat, Sleep, Console …

Tens of thousands of infants are impacted yearly by prenatal opioid exposure. The term
neonatal opioid withdrawal syndrome (NOWS) is now replacing the more familiar term …